Prevention of postmenopausal bone loss by pulsed estrogen therapy: Comparison with transdermal route

Maturitas

Volumn 48, Issue 2, 2004, Pages 85-96

  Delmas, Pierre D ^a   Marianowski, Longin ^b   De Castro Perez, Antonio ^c   Ribot, Claude ^d   Pornel, Bruno ^e   Palacios, Santiago ^f   Lopes, Patrice ^g  

^a UNIVERSITÉ LYON 1   (France)

^b Clinic of Gynaecology and Obstetrics   (Poland)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d CHU RANGUEIL   (France)

^e Brussels Menopause Center   (Belgium)

^f Palacios Institute   (Spain)

^g NONE

Author keywords

Bone loss; Estrogen therapy; Postmenopausal

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; ESTRADIOL; OSTEOCALCIN; S 21400;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG PULSE THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; EPISTAXIS; ERYTHEMA; ESTROGEN THERAPY; FEMALE; FLU LIKE SYNDROME; HEADACHE; HIP; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; MULTICENTER STUDY; OSTEOPENIA; PHARYNGITIS; POSTMENOPAUSE OSTEOPOROSIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; RHINITIS; SKIN DEFECT; SKIN PIGMENTATION; SKIN TINGLING; SNEEZING; SPINE; STATISTICAL SIGNIFICANCE; VAGINA BLEEDING; X RAY ANALYSIS;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ALKALINE PHOSPHATASE; BONE DENSITY; BONE REMODELING; ESTRADIOL; EUROPE; FEMALE; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PULSE THERAPY, DRUG; TREATMENT OUTCOME;

EID: 2542441543     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.01.012     Document Type: Article

References (23)

1. Melton L.J. Perspectives: how many women have osteoporosis now? J. Bone Miner. Res. 10:1995;175-177
2. The Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33.
3. Devissaguet J.P., Brion N., Lhote O., Deloffre P. Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (intranasal oestradiol) in postmenopausal women and comparison with oral and transdermal formulations. Eur. J. Drug Metab. Pharmacokinet. 24:1999;265-271
4. Studd J., Pornel B., Marton I., Bringer J., Varin C., Tsouderos Y., et al. Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomized dose-response study. Aerodiol Study Group. Lancet. 353:1999;1574-1578
5. Mattsson L.A., Christiansen C., Colau J.C., Palacios S., Kenemans P., Bergeron C., et al. Clinical equivalence of intranasal and oral 17 beta-estradiol for postmenopausal symptoms. Am. J. Obstet. Gynecol. 182:2000;545-552
6. Lopes P., Merkus H.M.W.M., Nauman J., Bruschi F., Foidart J.-M., Calaf J. Randomized comparison of intranasal and transdermal estradiol. Obstet. Gynecol. 96:2000;906-912
7. Wiklund I., Karlberg J., Mattson A. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double blind placebo-controlled study. Am. J. Obstet. Gynecol. 168:1993;824-830
8. The Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1996;276:1389-6.
9. Ettinger B., Genant H.K., Steiger P., Madvig P. Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women. Am. J. Obstet. Gynecol. 166:1992;479-488
10. Field C.S., Ory S.J., Wahner H.W., Herrmann R.R., Judd H.L., Riggs B.L. Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial. Am. J. Obstet. Gynecol. 168:1993;114-121
11. Delmas P.D., Pornel B., Felsenberg D., Garnero P., Hardy P., Pilate C. A dose-ranging trial of a matrix transdermal 17 beta-estradiol in the prevention of bone loss in early menopausal women. Bone. 24:1999;517-523
12. Cooper C., Stakkestad J.A., Radowicki S., Hardy P., Pilate C., Dain M.P., et al. for The International Study Group. Matrix delivery transdermal 17β-estradiol for the prevention of bone loss in postmenopausal women. Osteoporos. Int. 9:1999;358-366
13. Garnero P., Tsouderos Y., Marton I., Pelissier C., Varin C., Delmas P.D. Effects of intranasal 17 beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. J. Clin. Endocrinol. Metab. 84:1999;2390-2397
14. Weiss SR, Ellman H, Dolker M, for the Transdermal Estradiol Investigator Group. A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Obstet Gynecol 1999;94:330-6.
15. Daly E., Vessey M.P., Hawkins M.M., Carson J.L., Gough P., Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 348:1996;977-980
16. Jick H., Derby L.E., Myers M.W., Vasilakis C., Newton K.M. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet. 348:1996;981-983
17. Grodstein F., Stampfer M.J., Goldhaber S.Z., Manson J.E., Colditz G.A., Speizer F.E., et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet. 348:1996;983-987
18. Kroon U.B., Silfverstolpe G., Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb. Haemost. 71:1994;420-423
19. Scarabin P.Y., Alhenc-Gelas M., Plu-Bureau G., Taisne P., Agher R., Aiach M. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler. Thromb. Vasc. Biol. 17:1997;3071-3078
20. Lowe G.D.O., Upton M.N., Rumley A., McConnachie A., O'Reilly D.St.J., Watt G.C.M. Different effects of oral and transdermal hormone replacement therapies on factor IX, ACP resistance, t-PA, PAI and C-reactive protein. Thromb. Haemost. 86:2001;550-556
21. ® (intranasal estradiol) for 1 year. Maturitas. 36:2000;209-215
22. Lindsay R. The menopause and osteoporosis. Obstet. Gynecol. 87:1996;16S-19S
23. Felson D.T., Zhang Y., Hannan M.T., Kiel D.P., Wilson P.W., Anderson J.J. The effect of postmenopausal estrogen therapy on bone density in elderly women. N. Engl. J. Med. 329:1993;1141-1146